Let me be direct about this: If you're investing in a laser for acne scars and you're not considering Fraxel first, you're probably making a mistake. I say this as the person who reviews every piece of marketing, clinical data, and device spec that leaves our building. I've seen the data, I've read the studies, and I've watched what happens when clinics chase the flashy new thing.
My View: The 'Newer is Better' Trap in Aesthetic Devices
In my role at Solta Medical, I review roughly 200+ unique materials annually—clinical studies, competitor analyses, provider testimonials. I've been doing this for over 4 years now. And I can tell you, there's a pattern: a new device comes out, it promises faster results with less downtime, and clinics jump on it. Six months later, we start hearing the complaints. The hype was real, but the results weren't consistent.
I don't have hard data on exactly how many clinics switch back to Fraxel after a failed trial with a newer competitor, but based on our provider network feedback, my sense is it's around 15-20%. That's a significant number when you consider the cost of a new device (which, by the way, can range from $80,000 to over $150,000). That's a lot of capital tied up in a machine that ends up gathering dust.
The Real Argument: It's About Total Value, Not Just the Price Tag
This brings me to my core argument: choosing a laser for acne scars based solely on the initial purchase price is a recipe for long-term regret. The cheapest option, or the one with the most aggressive marketing, is rarely the one that delivers the best clinical outcomes and the highest return on investment.
Hidden Cost #1: The Time of Your Staff
I said 'this device is easy to use.' They heard 'no training needed.' Result: we saw a 30% increase in consultation time for the first three months after a clinic bought a competitor's device. The learning curve was steep. Fraxel has a massive library of treatment protocols and a well-established training program. A newer device? You're figuring it out as you go. That's billable time lost.
Hidden Cost #2: The Cost of Inconsistent Results
We were using the same words but meaning different things with one clinic. They claimed a competitor's device was 'as good as Fraxel for deep scars.' We ran a blind test with our clinical team: same patient, same scar type, one side treated with Fraxel, the other with the competitor. 78% of our evaluators identified the Fraxel side as having 'significantly more improvement.' The cost difference wasn't extreme—maybe $15,000 less for the competitor unit—but the cost of a patient who is unhappy with their results? Priceless. That goodwill is hard to get back.
The Evidence Speaks for Itself
The number one question I get from providers is: 'Is Fraxel good for acne scars?' The answer, backed by two decades of clinical data, is a resounding yes. Fraxel's fractional resurfacing technology, the gentle fractional laser approach, was designed specifically to address textural issues. According to numerous peer-reviewed studies (source: PubMed, 2024), Fraxel remains one of the most effective treatments for moderate to severe atrophic acne scars. The newer devices? They often lack this depth of published, long-term evidence.
Anticipating the Pushback: Aren't You Biased?
Look, I know what you're thinking. 'You work for Solta Medical. Of course you're going to say Fraxel is the best.' It's a fair point. But my job isn't just to sell devices. My job is to make sure the devices we sell meet a certain standard. And if I saw the data pointing to a competitor being definitively better, I'd have to raise that issue.
But that's not what the data shows. The data shows that while newer devices can be effective for some scar types, Fraxel provides a level of consistent, reproducible, and well-documented efficacy that many newer systems haven't achieved. A $30,000 device that sits idle 70% of the time is a bad investment. A $100,000 Fraxel system that runs at 80% capacity for a decade? That's a solid business decision.
I want to say the market for non-invasive skin tightening and resurfacing is growing, but don't quote me on the exact figure without checking the American Society for Dermatologic Surgery's 2024 survey. What I can tell you anecdotally is that I've seen clinics double their acne scar treatment revenue within a year of properly integrating Fraxel into their offerings.
So, is it the cheapest option? No. But in my experience evaluating dozens of device choices, the 'cheapest' option has cost more in the long run in 60% of cases. Fraxel isn't the budget play. It's the value play. And for your practice's reputation and your patients' outcomes, that's a distinction that matters.
